Inovio Pharmaceuticals, Inc. INO
1.45 USD -0.06 (-3.97%)
At closeNov 10, 2026, 7:59 PM EST
1.35 -0.10 -6.90%
After hours · Nov 10, 7:59 PM ET
1.41 Day range 1.51
0.56 52-week range 2.72
- YTD
- -16.67%
- 1 year
- -32.56%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 65.34K | 217.76K | 832.01K | 10.26M | 1.77M | |
| 65.34K | 217.76K | 832.01K | 10.26M | 1.77M | |
| -86.82M | -112.40M | -143.94M | -267.57M | -301.22M | |
| -84.95M | -107.25M | -135.12M | -279.82M | -303.66M | |
| -1.81 | -3.95 | -6.09 | -14.07 | -17.45 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 44.27M | 65.81M | 14.31M | 46.33M | 71.14M | |
| 74.31M | 113.20M | 170.95M | 348.53M | 495.94M | |
| 50.21M | 44.69M | 53.60M | 126.17M | 96.27M | |
| 9.37M | 11.87M | 30.21M | 32.07M | 33.02M | |
| 24.10M | 68.50M | 117.35M | 222.36M | 399.67M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -88.63M | -104.08M | -124.37M | -216.22M | -215.71M | |
| 14.04M | 104.07M | 87.36M | 109.59M | -175.34M | |
| 53.05M | 51.48M | 5.00M | 81.84M | 211.50M | |
| -285.70K | -428.51K | 5.90M | -969.15K | -1.23M | |
| -21.54M | 51.50M | -32.02M | -24.81M | -179.58M |